Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...
Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and ...
An announcement from Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) is now available. Shanghai Henlius Biotech, Inc. announced that its New ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Delving into the opportunities for PE firms – including Diversis, GHO, InTandem and Summit Partners – to invest in healthcare ...
Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...
An enzyme found in papaya could lead to new medicines: a scientific review reveals the surprising pharmaceutical potential of ...
China Releases First Novel Drugs List for Commercial Insurance, With CAR-T Therapies Leading the Way
(Yicai) Dec. 8 -- China introduced its first Commercial Health Insurance Innovative Drug List that includes five chimeric ...
Ms. Ishak brings more than 25 years of corporate legal and strategic leadership experience in the life sciences industry ...
Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias ...
Deputy Prime Minister Nguyen Chi Dung and Genetica CEO highlight AI-biotech convergence as Vietnam aims to establish its first regional biohub by early 2026.
Partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate to treat degenerative disorders of retina, with view to starting clinical trials in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback